NUTX
Nutex Health Inc.$208.25 −0.76 (−0.36%)
Oct 27 4:00 PM ET · prev $209.01
Market cap
$1.4B
Small cap
Consensus
Buy
91% Buy or better · 11 analysts
Median target
🔒 Subscribers only
Next earnings
Nov 17
in 21 days
1 year
+61.8%
from $128.68 · Oct 28
30 days
−2.1%
from $212.74
52-week range
$87.01–225.00
−7% from high · low Mar 12
Avg volume 20D
146.0K
shares / day
Short interest
1.24M
≈18.1% of shares · −1.1%
Days to cover
7.6
at average volume
Insider net
+$2.2K
4 buyers · 1 seller · 12 mo
New fund stakes
2
Q2 2026 13F · 0 exits
SecBot read BULLISH 3 reports · 90 days
Balance 0 bearish · 1 bullish · 1 mixed · 1 neutral oldest → newest, height = score
Avg score ·High conf. 2/3 ·Next Earnings date, Nov 17, 2026
Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
No data for this timeframe.
- R Mar 5 Nutex Health reported strong full-year 2025 financial results with r…
- B Mar 13 to Mar 20 4 days of insider buys: $45.7K by 4 insiders, avg $93.09
- R May 8 The Texas Court of Appeals affirmed the trial court's denial of Nute…
- A Jun 26 B. Riley Securities initiates
- R Aug 6 Nutex Health reported Q2 2026 diluted EPS of $9.38, a 78% beat vs th…
- R Aug 13 The Fifth Circuit en banc vacated key provisions of the July 2021 in…
- S Sep 18 1 insider sell $43.5K at $214.25
- A Oct 26 Ladenburg Thalmann initiates
Signal stack
Where each data set points today.
- InsidersMIXED
4 insiders bought $45.7K at an average $93.09. 1 insider sold $43.5K. Price is 124% above their cost.
- InstitutionsBULLISH
Q2 2026: 18 added (2 new), 10 trimmed or exited. Largest new: D. E. Shaw & ., $16.7M, Focus Partners Wealth $10.4M.
- AnalystsBULLISH
10 of 11 rate it Buy or better.
- Short sellersSTEADY
Short interest −1.1% to 1.24M shares. 7.6 days to cover, ≈18.1% of shares.
- TrendRANGE
3% above its 50-day average.
Who's buying
13F· Q2 20262
new positions
0
exits
$27.1M
in new stakes
| Fund | Move | Value |
|---|---|---|
| D. E. Shaw & Co., Inc. | NEW | $16.7M |
| Focus Partners Wealth | NEW | $10.4M |
| MILLENNIUM MANAGEMENT LLC | TRIM | $8.9M |
| GOLDMAN SACHS GROUP INC | ADD | $8.8M |
| Empowered Funds, LLC | ADD | $7.7M |
| VICTORY CAPITAL MANAGEMENT INC | TRIM | $5.0M |
| BARCLAYS PLC | ADD | $3.8M |
| MORGAN STANLEY | TRIM | $3.3M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
11 analysts 91% rate it Buy or better
Recent actions
| Date | Firm | Rating |
|---|---|---|
| Oct 26, 2026 | Ladenburg Thalmann INITIATE | Buy |
| Sep 25, 2026 | Freedom Capital Markets MAINTAIN | Buy |
| Sep 4, 2026 | B. Riley Securities MAINTAIN | Buy |
| Aug 11, 2026 | Lake Street MAINTAIN | Buy |
| Jun 26, 2026 | B. Riley Securities INITIATE | Buy |
| Jun 2, 2026 | Lake Street INITIATE | Buy |
Insider ledger
Form 4$45.7K
bought · 4 insiders
$43.5K
sold · 1 insider
+123.7%
vs their $93.09 cost
| Date | Insider | Type | Value |
|---|---|---|---|
| Sep 18, 2026 | Saunders Scott J Director | SELL | $43.5K |
| Jul 31, 2026 | Grenas Cheryl Yvonne Director | EXERCISE | 603 sh |
| Jul 31, 2026 | Jaumot Frank E Director | EXERCISE | 603 sh |
| Jul 31, 2026 | Saunders Scott J Director | EXERCISE | 603 sh |
| Jul 31, 2026 | Reed Michael Lee Director | EXERCISE | 603 sh |
| Jun 4, 2026 | Spears Kelvin Director | OTHER | 2,519 sh |
| May 28, 2026 | Vo Thomas T. Chief Executive Officer | OTHER | 75,747 sh |
| Apr 23, 2026 | Grenas Cheryl Yvonne Director | AWARD | 823 sh |
Earnings setup
EstimatesNov 17
reports in 21 days
Revision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
Short side
FINRA· Oct 15, 20261,237,099
shares short
-1.1%
vs prior settlement
7.6
days to cover
≈18.1%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 19, 2026 SEC Aug 6, 2026 SEC
Nutex Health, Inc. announced it will host a conference call on November 5, 2026 to discuss its Q3 2026 results.
PRESS-RELEASE — Impact 1/10
Oct 19, 2026 Earnings
Nutex Health Schedules 2026 Third Quarter Financial Results Release and Conference Call
HOUSTON, Oct. 19, 2026 /PRNewswire/ -- Nutex Health, Inc. (NASDAQ: NUTX), a physician-led, integrate
Sep 18, 2026 Insider
Aug 13, 2026 SEC Saunders Scott J sold 203 shares
Director @ $214.25 ($43.5K)
The Fifth Circuit en banc vacated key provisions of the July 2021 interim final rule under the No Surprises Act…
8-K — Impact 6/10
Nutex Health reported Q2 2026 diluted EPS of $9.38, a 78% beat vs the $5.26 consensus, driven by a one-time $52.3M…
PRESS-RELEASE — Impact 6/10
Jul 31, 2026 Insider
Grenas Cheryl Yvonne acquired via exercise 603 shares
Director
Jul 31, 2026 Insider
Jaumot Frank E acquired via exercise 603 shares
Director
Jun 30, 2026 Inst.
D. E. Shaw & — NEW
97,454 shares ($16.7M)
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Recent
Oct 19, 2026
Earnings
Nutex Health Schedules 2026 Third Quarter Financial Results Release and Conference Call
HOUSTON, Oct. 19, 2026 /PRNewswire/ -- Nutex Health, Inc. (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 28…
Sep 22, 2026
Press release
Nutex Health Approved for Dual Listing on Nasdaq Texas
HOUSTON, Sept. 22, 2026 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX) today announced that it has received…
Sep 10, 2026
Press release
NUTEX HEALTH PROVIDES UPDATE REGARDING CYBERSECURITY EVENT
HOUSTON, Sept. 10, 2026 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), today provided an update regarding its…
Aug 31, 2026
Earnings
Nutex Health Hospitals Earn Multiple Community Honors in Second Quarter 2026
HOUSTON, Aug. 31, 2026 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare…
Aug 25, 2026
Press release
Fifth Circuit Rejects "Ghost Rates" in Federal QPA Calculations Under the No Surprises Act
HOUSTON, Aug. 25, 2026 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated health care…
SecBot reports
7 filings · 2 bullish · 1 bearish · 1 mixed · 3 neutral- NEUTRAL PRESS-RELEASEOct 19, 2026
Nutex Health, Inc. announced it will host a conference call on November 5, 2026 to discuss its Q3…
- BULLISH 8-KAug 13, 2026
The Fifth Circuit en banc vacated key provisions of the July 2021 interim final rule under the No…
The ruling removes a key headwind for provider reimbursement under the NSA. Monitor HHS rulemaking timeline and any subsequent guidance for implementation. The stock may re-rate on improved…
- MIXED PRESS-RELEASEAug 6, 2026
Nutex Health reported Q2 2026 diluted EPS of $9.38, a 78% beat vs the $5.26 consensus, driven by a…
The massive EPS beat is non-recurring and tied to a retroactive contract amendment and regulatory fee cut. Traders should focus on the sustainability of the 25-30% prospective reduction in…
- NEUTRAL PRESS-RELEASEJul 21, 2026
Nutex Health, Inc. announced it will host a conference call on August 6, 2026 to discuss its Q2…
All NUTX filing & press-release reports (7)
- PRESS-RELEASE reportOct 19, 2026
- 8-K reportAug 13, 2026
- PRESS-RELEASE reportAug 6, 2026
- PRESS-RELEASE reportJul 21, 2026
- COURT-RULING reportMay 8, 2026
- CLUSTER reportMar 13, 2026
- 8-K reportMar 5, 2026